Purchase Order HHSN263201700328A
Award Date 6/7/17
Potential Completion Date 12/10/20
Potential Value $411K
Federal Agency
Awardee
Ultimate Awardee
Not listed Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Bethesda, MD 20892, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Environmental Health Sciences to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The delivery order, valued at $203,295.35, is for the supply of Illumina's proprietary sequencing instruments, reagents, and related products and services, to support the agency's genomic research and analysis needs. The contract has a...
- This is a firm fixed price delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases to Illumina, Inc., a for-profit manufacturer of genomic sequencing instruments and reagents. The $144,182.10 contract is to provide Illumina sequencing systems, reagents, and related products and services to support genomic research and analysis at the NIH. Illumina has a history of...
- This firm fixed-price delivery order contract was awarded by the National Human Genome Research Institute, a civilian agency under the National Institutes of Health (NIH), to Illumina, Inc., a manufacturer of genetic sequencing instruments and bioinformatics products. The $131,931.29 contract is for the provision of various Illumina sequencing systems, reagents, consumables, and related goods and services to support genomic research and analysis. This award is not associated with a set-aside...
- This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, a civilian agency within the National Institutes of Health, to Illumina, Inc., a manufacturer of sequencing and genomic analysis products. The contract, valued at $100,213.37, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance...
- This is a firm fixed price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency, to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The award, valued at $135,908.52, is for the provision of Illumina's NextSeq, NovaSeq, MiSeq, and iSeq sequencing platforms, along with accompanying reagents, consumables, sample preparation kits, sequencing chips, support plans, maintenance services, and bioinformatics...
- This is a firm fixed price delivery order awarded by the National Human Genome Research Institute (NHGRI), a component of the National Institutes of Health (NIH), to Illumina, Inc. The total ceiling value of the contract is $86,989.68. Illumina, a manufacturer of sequencing and genomic analysis instruments and reagents, is providing a range of goods and services to support genomic sequencing and analysis for research and diagnostics purposes. This includes various NextSeq, NovaSeq, MiSeq, and...
- This is a firm fixed price purchase order awarded by the National Human Genome Research Institute (NHGRI), which is part of the National Institutes of Health (NIH), a civilian agency. The contract, valued at $770,306.04, was awarded to Illumina, Inc., a manufacturer of sequencing and array-based solutions for genetic and genomic analysis. The contract does not have a set-aside designation. Under this contract, Illumina will provide a range of goods and services to support genomic sequencing...
- This is a firm fixed-price delivery order contract awarded by the National Human Genome Research Institute, part of the National Institutes of Health, to Illumina, Inc. The total ceiling value of the contract is $16,851.34 with a final completion date of September 1, 2025. Illumina, a for-profit manufacturer of genomic sequencing and analysis instruments and reagents, has been awarded this contract to provide a range of its NextSeq, NovaSeq, MiSeq, and iSeq sequencing systems, as well as...
- This is a firm fixed-price purchase order awarded by the National Human Genome Research Institute (NHGRI), a civilian agency within the National Institutes of Health (NIH), to Illumina, Inc., a leading manufacturer of genetic sequencing and genomic analysis technologies. The $195,464.40 contract provides for Illumina Sequencers Service Agreement, which includes the procurement of advanced sequencing instruments like NextSeq, NovaSeq, MiSeq, and iSeq systems, along with associated reagents,...
- This is a firm fixed price delivery order contract awarded by the National Institute of Environmental Health Sciences (NIEHS), a civilian agency under the Department of Health and Human Services, to Illumina, Inc. The $103,374.14 contract is for the provision of Illumina's sequencing systems, reagents, and related services to support genomic sequencing and analysis for research and diagnostic purposes. The contract has no set-aside designation. Illumina has previously been awarded prime...